CJC-1295 without DAC occupies the sweet spot: longer-acting than sermorelin (which degrades too fast for reliable clinical effect), shorter-acting than DAC (which sacrifices pulsatility), and considerably cheaper than tesamorelin (the only FDA-approved option in this class)
But heres something most people dont realize: your body already makes GLP-1
BioMed Research International, 2015 , 648108
Understanding this distinction is foundational to making an informed decision
The underlying mechanisms may include the presence of AR-Vs, differential actions of AR co-regulators, epigenetics, and tumor microenvironment
Similarly, eating patterns adopted during treatmenthigher protein intake, whole-grain carbohydrates, reduced ultra-processed foodsbecome easier to maintain when GLP-1 medication continues supporting satiety signals